Effects of metronidazole and its metabolites on histamine immunosuppression activity.

[1]  P. Ostrosky-Wegman,et al.  Metronidazole hprt mutation induction in sheep and the relationship with its elimination rate. , 1994, Mutation research.

[2]  S. Schwartz,et al.  Levamisole as an immunopotentiator for T cell deficiency. , 1994, Immunopharmacology and immunotoxicology.

[3]  P. Ostrosky-Wegman,et al.  Lymphocyte proliferation kinetics and sister-chromatid exchanges in individuals treated with metronidazole. , 1994, Mutation research.

[4]  D. Reis,et al.  Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells. , 1991, Molecular pharmacology.

[5]  G. Tucker,et al.  Characterization of metronidazole metabolism by human liver microsomes. , 1991, Biochemical pharmacology.

[6]  D. Atlas,et al.  Imidazoline receptors in rat liver cells: A novel receptor or a subtype of α2-adrenoceptors? , 1990 .

[7]  T. Ishikawa,et al.  Binding of [3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain , 1990, Brain Research.

[8]  T R Fleming,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[9]  S. Loft,et al.  Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition. , 1989, Biochemical pharmacology.

[10]  W. Black,et al.  Parainfluenza-3 virus-induced enhancement of histamine release from calf lung mast cells--effect of levamisole. , 1988, Journal of veterinary pharmacology and therapeutics.

[11]  D. Reis,et al.  An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla , 1988, Brain Research.

[12]  K. Melmon,et al.  Histamine and its lymphocyte-selective derivatives as immune modulators , 1987 .

[13]  H. Sjögren,et al.  Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-γ production , 1987 .

[14]  M. Dohlsten,et al.  Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells. , 1985, Cellular immunology.

[15]  D. Norris,et al.  3H-cimetidine and the H2-receptor. , 1983, Life sciences.

[16]  S. Suzuki,et al.  Properties of histamine-induced suppressor factor in the regulation of lymphocyte response to PHA in mice. , 1982, Cellular immunology.

[17]  R. Mccaffrey,et al.  SUCCESSFUL TUMOUR IMMUNOTHERAPY WITH CIMETIDINE IN MICE , 1981, The Lancet.

[18]  S. Enna,et al.  Properties of 3H-cimetidine binding in rat brain membrane fractions. , 1980, Life sciences.

[19]  S. Hatfield,et al.  Cimetidine-induced augmentation of human lymphocyte blastogenesis by mitogen, bacterial antigen, and alloantigen. , 1980, Transplantation.

[20]  R. Willson,et al.  Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. , 1976, British Journal of Cancer.

[21]  R. Rocklin.  Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. , 1976, The Journal of clinical investigation.

[22]  A. Badger,et al.  In vitro stimulation of murine lymphoid cell cultures by levamisole. , 1975, Clinical and experimental immunology.

[23]  J. Hadden,et al.  Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. , 1975, Cellular immunology.

[24]  S. Wolff,et al.  New Giemsa method for the differential staining of sister chromatids , 1974, Nature.

[25]  G. Renoux,et al.  Antigenic competition and nonspecific immunity after a rickettsial infection in mice: restoration of antibacterial immunity by phenyl-imidothiazole treatment. , 1972, Journal of immunology.

[26]  R. Khambatta.  Metronidazole in giardiasis. , 1971, Annals of tropical medicine and parasitology.

[27]  H. Bourne,et al.  Histamine Augments Leukocyte Adenosine 3',5'-Monophosphate and Blocks Antigenic Histamine Release , 1971, Science.

[28]  J. Stambaugh,et al.  The isolation and identification of the urinary oxidative metabolites of metronidazole in man. , 1968, The Journal of pharmacology and experimental therapeutics.

[29]  J. Cravioto,et al.  A new dosing regimen for metronidazole in malnourished children. , 1993, Scandinavian journal of infectious diseases.

[30]  K. Markiewicz,et al.  Changes in the interleukin-1 and interleukin-2 generation in duodenal ulcer patients during cimetidine treatment. , 1985, Immunology letters.

[31]  S. Powell.  Latest developments in the treatment of amebiasis. , 1972, Advances in pharmacology and chemotherapy.